1-(3-Bromophenyl)-2-hydroxyethan-1-one, 95%, 10g

4-Acridinecarboxamide, N-[4-[2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-, hydrochloride (1:1), 98%, 100mg

2-Butyl-5-chloro-1H-imidazole-4-carboxaldehyde>98.0%(GC)25g

3-(2-Fluoro-phenoxy)-propionic acid, 95.0%, 500mg

L-GLUTAMIC ACID-15N, 95.0%, 250mg

4,4,5,5-Tetramethyl-2-(4-((4-methylbenzyl)oxy)phenyl)-1,3,2-dioxaborolane, 25g

(S)-tert-butyl 6-(hydroxymethyl)-2,2-dimethylmorpholine-4-carboxylate, 95.0%, 250mg

2-Benzylmorpholine, 95.0%, 1g

(2S,4R)-tert-Butyl 4-hydroxy-2-methylpyrrolidine-1-carboxylate, 95.0%, 5g

(S)-2-((tert-Butoxycarbonyl)amino)-3-(3,4-dihydroxyphenyl)propanoic acid, 97%, 100mg

3-Chloro-2-(difluoromethoxy)-6-(trifluoromethyl)pyridine, 98%, 1g

5-Chloroquinoxaline, 95.0%, 10g

(R)-2,6-Bis(((benzyloxy)carbonyl)amino)hexanoic acid, 97%, 10g